A journey of excellence by a quintessential rheumatologist Robert James Lloyd Jr., MD, FACP, MACR, passed away peacefully on Feb. 4, 2024, at his home in Falls Church, Va. Bob, as he was known to loved ones, was born in Washington, D.C., on Jan. 6, 1943. He grew up in Providence, R.I., where he attended…
When patients have questions, can artificial intelligence (AI) generate accurate, comprehensive answers? Ye et al. conducted a single-center, cross-sectional survey of rheumatology patients and physicians in Edmonton, Canada, to explore that question.
Editor’s note: Originally published on Oct. 12, 2023. Updated Feb. 28, 2024, to add fact sheets. According to the Agency for Healthcare Research and Quality (AHRQ), a leading cause of medical errors and poor care is a lack of communication between healthcare providers.1 As healthcare has evolved, the importance of holistic care has become more…
Experts described the latest breakthroughs related to lupus and the brain, including the use of functional magnetic resonance imaging (fMRI) to gain insights into brain fog. Research into the role of microglia in neuropsychiatric lupus is also described.
Gaining trust has a significant effect on disease management and patient care, according to experts at ACR Convergence 2023. Here are insights into the barriers to that trust and how healthcare providers can develop trusting relationships with their patients.
In January, the U.S. Food & Drug Administration approved indomethacin in an oral suspension, a generic version of Indocin Oral Suspension. The agency also issued a boxed warning and updated label for denosumab, warning of the risks of severe hypocalcemia in patients with chronic kidney disease.
In this episode, Dr. Kumar discusses concepts of time, flow and what they mean for the patient experience and the rheumatologist.
The implementation of the new G2211 code on Jan. 1 increases reimbursement for rheumatology visits, but the ACR continues to fight for retroactive repayment of the across-the-board Medicare physician reimbursement cuts implemented at the same time, as well as structural changes to the program to make serving Medicare patients sustainable for rheumatologists in the long term.
Through a project to reduce gaps and inequities in lupus care and treatment, ACR work groups have developed five quality measures focused on clinical and patient-reported outcomes and are integrating them into the RISE registry to support patient care and research.
A free, tailored, one-hour series on coding and compliance for G2211 will help rheumatology practices bill correctly with the new add-on code to maximize reimbursements and minimize claim denials or rejections.